Reprogramming the Immune System: How Cancer’s CAR T Therapy is Being Pivoted to Fight Autoimmune Disease

Originally designed for leukemia, CAR T cell therapy is now entering clinical trials for MS, lupus, and stiff person syndrome, promising a systemic ‘reset’.